Evotec SE (EVO)
NASDAQ: EVO · IEX Real-Time Price · USD
4.950
+0.090 (1.85%)
At close: Jul 2, 2024, 4:00 PM
4.980
+0.030 (0.61%)
After-hours: Jul 2, 2024, 6:34 PM EDT
Evotec SE Employees
Evotec SE had 4,952 employees as of December 31, 2022. The number of employees increased by 754 or 17.96% compared to the previous year.
Employees
4,952
Change (1Y)
754
Growth (1Y)
17.96%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
1.76B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 4,952 | 754 | 17.96% |
Dec 31, 2021 | 4,198 | 3,995 | 1,967.98% |
Dec 31, 2009 | 203 | 0 | - |
Dec 31, 2008 | 203 | 0 | - |
Dec 31, 2007 | 203 | -396 | -66.11% |
Dec 31, 2006 | 599 | -14 | -2.28% |
Dec 31, 2005 | 613 | -26 | -4.07% |
Dec 31, 2004 | 639 | -7 | -1.08% |
Dec 31, 2003 | 646 | 27 | 4.36% |
Dec 31, 2002 | 619 | 34 | 5.81% |
Dec 31, 2001 | 585 | 277 | 89.94% |
Dec 31, 2000 | 308 | 110 | 55.56% |
Dec 31, 1999 | 198 | 72 | 57.14% |
Dec 31, 1998 | 126 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
National HealthCare | 13,123 |
Teladoc Health | 5,600 |
Zai Lab | 2,175 |
Veracyte | 815 |
Recursion Pharmaceuticals | 500 |
Immunocore Holdings | 497 |
Harmony Biosciences Holdings | 246 |
Morphic Holding | 121 |
EVO News
- 7 days ago - Just - Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program - Accesswire
- 20 days ago - Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb - Accesswire
- 22 days ago - Evotec SE: Results of the Annual General Meeting 2024 - Accesswire
- 6 weeks ago - Evotec SE to Announce Results for First Quarter 2024 on 22 May 2024 - Accesswire
- 2 months ago - Bayer and Evotec Collaborate to Advance Precision Cardiology - Accesswire
- 2 months ago - Evotec shares lose a third of their value on cloudy outlook - Market Watch
- 2 months ago - Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset to Focus on Profitable Growth - Accesswire
- 2 months ago - Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer - Accesswire